Announcement on Voluntary Disclosure of the Initiation of Phase I/II Clinical Trial for YLSH003 for Injection and Completion of the 1st Subject Enrollment

About this update from Chengdu Easton Biopharmaceuticals Co., Ltd. Class A

Announcement on Voluntary Disclosure of the Initiation of Phase I/II Clinical Trial for YLSH003 for Injection and Completion of the 1st Subject EnrollmentThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Chengdu Easton Biopharmaceuticals Co., Ltd. Class A